Sensei Biotherapeutics, Inc. Common Stock (SNSE) is a publicly traded Healthcare sector company. As of May 21, 2026, SNSE trades at $17.58 with a market cap of $26.70M and a P/E ratio of -1.04. SNSE moved +4.59% today. Year to date, SNSE is +80.68%; over the trailing twelve months it is +167.91%. Its 52-week range spans $5.00 to $36.76. Rallies surfaces SNSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SNSE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SNSE recently traded at $17.58. Market cap is $26.70M. P/E ratio is -1.04. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $17.58 |
| Market Cap | $26.70M |
| P/E Ratio | -1.04 |
| EPS | $-16.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.76 |
| 52-Week Low | $5.00 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-21.09M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-21.09M | $-16.72 |
| 2024 | $0 | $-30.16M | $-1.20 |
| 2023 | $0 | $-34.10M | $-1.22 |
| 2022 | $0 | $-48.59M | $-1.58 |
SNSE analyst coverage data. Average price target: $0.00.